FDA Approved: BORTEZOMIB — Original Application (Apotex Corp)

View source ↗

Summary

FDA approves Apotex Corp's original application for a generic Bortezomib product under ANDA205533.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

ORIG AP for BORTEZOMIB (BORTEZOMIB)